SCHEDULE 13G/A: T. Rowe Price Associates Discloses Significant Stake in Natera Inc.
Beneficial Ownership Disclosure
T. Rowe Price Associates, Inc. has reported a 7.8% beneficial ownership stake in Natera Inc., holding over 10.5 million shares as of March 31, 2025.
Summary
- T. Rowe Price Associates, Inc. filed an Amendment No. 1 to Schedule 13G, disclosing its beneficial ownership in NATERA INC.
- As of March 31, 2025, T. Rowe Price Associates, Inc. beneficially owns an aggregate of 10,554,721 shares of NATERA INC's Common Stock.
- This ownership represents 7.8% of the total class of securities.
- T. Rowe Price Associates, Inc. holds sole voting power over 10,103,376 shares and sole dispositive power over 10,552,584 shares.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of NATERA INC.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership by an institutional investor and does not contain qualitative information to assess sentiment beyond the fact of the investment itself.
Positives
- A significant institutional investor, T. Rowe Price Associates, Inc., holds a substantial 7.8% stake in Natera Inc., indicating their investment interest in the company.
Future Outlook
Not applicable. This document is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from the issuer.
Industry Context
This filing is a standard disclosure of an institutional investor's stake in a publicly traded company. It does not provide information on Natera Inc.'s operational performance or broader industry trends, but rather reflects an investment decision by T. Rowe Price Associates, Inc. within the healthcare or biotechnology sector where Natera operates.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional holdings, which can influence market perception.
- Company Management: Awareness of a major institutional investor's stake and potential interest in corporate governance.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which required the filing of this statement (ownership threshold crossed). |
| 05/14/2025 | Date of filing of the Schedule 13G Amendment No. 1. |
Keywords
Natera Inc, T. Rowe Price, Schedule 13G, beneficial ownership, common stock, institutional investment, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.